Fig. 2
From: Dapagliflozin in peritoneal dialysis patients: a pilot study evaluating peritoneal membrane function
Changes in glucose D4/D0 after 30 days of treatment with Dapagliflozin in CAPD patients. Modified PET with 4.25% Dextrose was performed before and 30 days after the daily dose of 10 mg Dapagliflozin. After treatment with Dapagliflozin, 13 patients had an increase of D4/D0 (dark blue) while 7 patients had a decrease (light blue). Change in of D4/D0 = [Post-treatment]—[Pre-treatment]. CAPD: Continuous Ambulatory Peritoneal Dialysis